Merit Medical Systems Announces Director Changes and Officer Compensation
Ticker: MMSI · Form: 8-K · Filed: May 16, 2024 · CIK: 856982
| Field | Detail |
|---|---|
| Company | Merit Medical Systems Inc (MMSI) |
| Form Type | 8-K |
| Filed Date | May 16, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $750,000, $475,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: MMSI
TL;DR
Merit Medical board shake-up: Lampropoulos out, new directors in, officer pay details released.
AI Summary
Merit Medical Systems, Inc. announced on May 15, 2024, the departure of Director Fred P. Lampropoulos and the election of new directors, including Scott R. Smith and Jeffrey S. Johnson. The company also reported on compensatory arrangements for its officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Director departures and changes in executive compensation can sometimes indicate underlying issues or strategic shifts that warrant closer investor scrutiny.
Key Players & Entities
- Merit Medical Systems, Inc. (company) — Registrant
- Fred P. Lampropoulos (person) — Departing Director
- Scott R. Smith (person) — Elected Director
- Jeffrey S. Johnson (person) — Elected Director
- May 15, 2024 (date) — Date of earliest event reported
FAQ
Who has departed from the Board of Directors at Merit Medical Systems, Inc.?
Fred P. Lampropoulos has departed from the Board of Directors.
Who has been elected as new directors to the Board?
Scott R. Smith and Jeffrey S. Johnson have been elected as new directors.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is May 15, 2024.
What specific items are being reported under Item Information in this filing?
The filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, other events, and financial statements and exhibits.
In which state was Merit Medical Systems, Inc. incorporated?
Merit Medical Systems, Inc. was incorporated in Utah.
Filing Stats: 723 words · 3 min read · ~2 pages · Grade level 10.3 · Accepted 2024-05-16 17:27:17
Key Financial Figures
- $750,000 — ors increased his annual base salary to $750,000, increased his target rate under Merit'
- $475,000 — icted stock units with a value equal to $475,000. Item 8.01. Other Events . Merit's p
Filing Documents
- mmsi-20240516x8k.htm (8-K) — 47KB
- mmsi-20240516xex99d1.htm (EX-99.1) — 11KB
- mmsi-20240516x8k001.jpg (GRAPHIC) — 11KB
- 0000856982-24-000045.txt ( ) — 209KB
- mmsi-20240516.xsd (EX-101.SCH) — 3KB
- mmsi-20240516_lab.xml (EX-101.LAB) — 15KB
- mmsi-20240516_pre.xml (EX-101.PRE) — 9KB
- mmsi-20240516x8k_htm.xml (XML) — 5KB
01. Other Events
Item 8.01. Other Events . Merit's press release announcing the appointment of Mr. Wright as Merit's President is attached hereto as Exhibit 99.1. The information contained in Exhibit 99.1 is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits EXHIBIT NUMBER DESCRIPTION 99.1 Press Release, dated May 15, 2024, entitled "Merit Medical Executive Leadership Team Update" 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MERIT MEDICAL SYSTEMS, INC. Date: May 16, 2024 By: /s/ Brian G. Lloyd Brian G. Lloyd Chief Legal Officer and Corporate Secretary 3